Zoetis Inc. Effective Income Tax Rate Reconciliation Fdii Percent
Zoetis Inc. (ZTS) reported Effective Income Tax Rate Reconciliation Fdii Percent of 1.50% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-02-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent · last filed 2026-02-12
- Zoetis Inc. effective income tax rate reconciliation fdii percent for fiscal 2024 was 1.50%, a 114.29% increase from fiscal 2023.
- Zoetis Inc. effective income tax rate reconciliation fdii percent for fiscal 2023 was 0.70%, a 250.00% increase from fiscal 2022.
- Zoetis Inc. effective income tax rate reconciliation fdii percent for fiscal 2022 was 0.20%, a 81.82% decline from fiscal 2021.
- Zoetis Inc. effective income tax rate reconciliation fdii percent for fiscal 2021 was 1.10%.
| Period end | Effective Income Tax Rate Reconciliation Fdii Percent 12 month |
|---|---|
| 2024-12-31 | 1.50% 10-K · filed 2026-02-12 |
| 2023-12-31 | 0.70% 10-K · filed 2026-02-12 |
| 2022-12-31 | 0.20% 10-K · filed 2025-02-13 |
| 2021-12-31 | 1.10% 10-K · filed 2024-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |